Literature DB >> 3266151

Effect of magnesium hydroxide on the absorption of tolfenamic and mefenamic acids.

P J Neuvonen1, K T Kivistö.   

Abstract

The effect of various antacids on the absorption of tolfenamic and mefenamic acids has been investigated in three separate crossover studies, each consisting of four phases. Single doses of magnesium hydroxide (85 mg, 425 mg and 1700 mg) or of water (150 ml) were given by mouth to 6 healthy volunteers immediately after tolfenamic acid 400 mg (Study 1), and, using an identical study design, after mefenamic acid 500 mg (Study 3). In Study 2 sodium bicarbonate 1 g, aluminium hydroxide 1 g, an antacid preparation containing both aluminium and magnesium hydroxides, or water alone were ingested with tolfenamic acid 400 mg. Plasma concentrations of tolfenamic and mefenamic acids and their cumulative excretion in urine were determined up to 24 h. Magnesium hydroxide greatly accelerated, in a dose-dependent manner the absorption of both tolfenamic and mefenamic acids. The peak times in plasma were shortened by about 1 h by 425 mg and 1700 mg magnesium hydroxide, and the peak plasma concentrations of both fenamates were elevated up to 3-fold. The area under the plasma concentration-time curve between 0 and 1 h of tolfenamic acid was increased up to 7-fold and that of mefenamic acid up to 3-fold. The total bioavailability of tolfenamic and mefenamic acids was only slightly increased. Aluminium hydroxide alone and in combination with magnesium hydroxide significantly retarded the absorption and lowered the peak plasma concentration of tolfenamic acid. Sodium bicarbonate had no significant effect on its absorption. The interaction with magnesium hydroxide leads to higher and earlier peak plasma concentrations of the fenamates.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3266151     DOI: 10.1007/bf00558244

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  8 in total

1.  Effect of coadministration of aluminum and magnesium hydroxides on absorption of anticoagulants in man.

Authors:  J J Ambre; L J Fischer
Journal:  Clin Pharmacol Ther       Date:  1973 Mar-Apr       Impact factor: 6.875

2.  Letter: Effects of antacids on naproxen absorption.

Authors:  E J Segre; H Sevelius; J Varady
Journal:  N Engl J Med       Date:  1974-09-12       Impact factor: 91.245

3.  Mefenamic acid overdosage.

Authors:  M Balali-Mood; J A Critchley; A T Proudfoot; L F Prescott
Journal:  Lancet       Date:  1981-06-20       Impact factor: 79.321

Review 4.  Drug-antacid interactions: assessment of clinical importance.

Authors:  P F D'Arcy; J C McElnay
Journal:  Drug Intell Clin Pharm       Date:  1987 Jul-Aug

Review 5.  Drugs, diseases and altered gastric emptying.

Authors:  W S Nimmo
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

6.  Human pharmacokinetics of tolfenamic acid, a new anti-inflammatory agent.

Authors:  P J Pentikäinen; P J Neuvonen; C Backman
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

7.  The application of statistical moment theory to the evaluation of in vivo dissolution time and absorption time.

Authors:  S Riegelman; P Collier
Journal:  J Pharmacokinet Biopharm       Date:  1980-10

8.  Effects of migraine attack and metoclopramide on the absorption of tolfenamic acid.

Authors:  R A Tokola; P J Neuvonen
Journal:  Br J Clin Pharmacol       Date:  1984-01       Impact factor: 4.335

  8 in total
  14 in total

1.  Differential effects of sodium bicarbonate and aluminium hydroxide on the absorption and activity of glipizide.

Authors:  K T Kivistö; P J Neuvonen
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 2.  Pharmacokinetic drug interactions with nonsteroidal anti-inflammatory drugs.

Authors:  R K Verbeeck
Journal:  Clin Pharmacokinet       Date:  1990-07       Impact factor: 6.447

Review 3.  Clinically significant drug interactions with antacids: an update.

Authors:  Ryuichi Ogawa; Hirotoshi Echizen
Journal:  Drugs       Date:  2011-10-01       Impact factor: 9.546

4.  The effect of magnesium hydroxide on the oral absorption of ibuprofen, ketoprofen and diclofenac.

Authors:  P J Neuvonen
Journal:  Br J Clin Pharmacol       Date:  1991-03       Impact factor: 4.335

5.  Effect of magnesium hydroxide on the absorption and efficacy of tolbutamide and chlorpropamide.

Authors:  K T Kivistö; P J Neuvonen
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

6.  Lack of effect of omeprazole or of an aluminium hydroxide/magnesium hydroxide antacid on the pharmacokinetics of lumiracoxib.

Authors:  Graham Scott; Christine Vinluan Reynolds; Slavica Milosavljev; Wayne Langholff; Magdy Shenouda; Christiane Rordorf
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

7.  The effects of magnesium hydroxide on the absorption and efficacy of two glibenclamide preparations.

Authors:  P J Neuvonen; K T Kivistö
Journal:  Br J Clin Pharmacol       Date:  1991-08       Impact factor: 4.335

Review 8.  Drug interactions with antacids. Mechanisms and clinical significance.

Authors:  D C Sadowski
Journal:  Drug Saf       Date:  1994-12       Impact factor: 5.606

9.  Effect of food on systemic exposure to niflumic acid following postprandial administration of talniflumate.

Authors:  Wonku Kang; Kibum Kim; Eun-Young Kim; Kwang-il Kwon; Jun Seok Bang; Young-Ran Yoon
Journal:  Eur J Clin Pharmacol       Date:  2008-07-08       Impact factor: 2.953

Review 10.  Enhancement of drug absorption by antacids. An unrecognised drug interaction.

Authors:  P J Neuvonen; K T Kivistö
Journal:  Clin Pharmacokinet       Date:  1994-08       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.